1. Clinical pharmacology of bispecific antibody constructs. (March 2015) Authors: Rathi, Chetan; Meibohm, Bernd; Korth‐Bradley, Joan; Mager, Donald; Meibohm, Bernd; Zhou, Hong Hui Journal: Journal of clinical pharmacology Issue: Volume 55:Number 3(2015:Mar.) Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice. (January 2019) Authors: Rathi, Chetan; Lukka, Pradeep B.; Wagh, Santosh; Lee, Richard E.; Lenaerts, Anne J.; Braunstein, Miriam; Hickey, Anthony; Gonzalez-Juarrero, Mercedes; Meibohm, Bernd Journal: Tuberculosis Issue: Volume 114(2019) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma. Issue 5 (4th October 2021) Authors: Ferron‐Brady, Geraldine; Rathi, Chetan; Collins, Jon; Struemper, Herbert; Opalinska, Joanna; Visser, Sandra; Jewell, Roxanne C. Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 5(2021) Page Start: 1282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pneumothorax leading to pneumopericardium after transvenous lead implantation in a patient with previous epicardial lead. Issue 3 (18th December 2020) Authors: Bansal, Raghav; Mahajan, Ankit; Rathi, Chetan; Lokhandwala, Yash Journal: Pacing and clinical electrophysiology Issue: Volume 44:Issue 3(2021) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma. (29th July 2021) Authors: Rathi, Chetan; Collins, Jon; Struemper, Herbert; Opalinska, Joanna; Jewell, Roxanne C.; Ferron‐Brady, Geraldine Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 8(2021) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Should Race‐Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling. (22nd December 2016) Authors: Patel, Chirag; Rathi, Chetan; Venkatakrishnan, Karthik Journal: Journal of clinical pharmacology Issue: Volume 57:Number 4(2017) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Translational PK/PD of anti-infective therapeutics. (September 2016) Authors: Rathi, Chetan; Lee, Richard E.; Meibohm, Bernd Journal: Drug discovery today Issue: Volume 21/22(2016) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. What is the mechanism of paroxysmal atrioventricular block in a patient with recurrent syncope?. Issue 6 (27th September 2019) Authors: Bansal, Raghav; Mahajan, Ankit; Rathi, Chetan; Mehta, Akshay; Lokhandwala, Yash Journal: Journal of arrhythmia Issue: Volume 35:Issue 6(2019) Page Start: 870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Where Is the Level of Atrioventricular Block?. Issue 17 (27th October 2020) Authors: Bansal, Raghav; Rathi, Chetan; Lokhandwala, Yash Journal: Circulation Issue: Volume 142:Issue 17(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗